glp 1 stands for what GLP-1 receptor agonists Unlocking the multifaceted roles of

Direct comparison is imperfect because the trials enrolled different populations, ran for different durations, and used different primary endpoints

Why this trial matters: First large Phase III evidence of biopsy-confirmed histologic benefit with a metabolic drug in MASH Demonstrates semaglutides impact beyond weight loss to disease-modifying liver effects Supports expanding GLP-1 therapeutics into liver disease care amid a high unmet need Ianalumab Meets Endpoints in Phase III Sjgrens Disease Trials (NEPTUNUS-1 & 2) Novartis reported that both Phase III studies of ianalumab achieved their primary endpoints in patients with Sjgrens disease, offering the first targeted therapy with statistically significant disease activity reduction in this chronic autoimmune disorder

Fiber and Gut Health Focus Anyone seeking to increase dietary fiber intakefor gut microbiome diversity, cardiovascular benefits, or satiety supportcan benefit from fiber supplements regardless of GLP-1 marketing

And GLP-1 drugs are one of the best tools that we have to ensure that the taxpayers are not going to pay more money for the health care of hundreds of millions of people in the long run. Its unclear whether the federal government will reverse course